Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pioglitazone effects in obese and non-obese newly diagnosed type 2 diabetes
ChiCTR-OPC-17011571Phase 4Completed
- Sponsor
- Fuwai Hospital
- Start
- Jun 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of pioglitazone in type 2 diabetes mellitus (T2DM) (2 cohorts), sponsored by Fuwai Hospital. Primary endpoints: Plasma glucose, Hemoglobin A1c and 3 more. Started Jun 2012; status: completed.
02
Drugs
pioglitazone
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on ChiCTR-OPC-17011571.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-OPC-17011571.